Human Longevity Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Human Longevity Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013535
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Human Longevity Inc (HLI) is a genomics-based, technology-driven company which develops database of whole genome, phenotype and clinical data. Its discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomarker and companion diagnostics. HLI primarily focuses on therapeutic areas such as cancer, diabetes and obesity, heart and liver diseases, and dementia. The company supports predictive, preventive and personalized care including the cancer analysis, integrated health analysis, newborn screening and rare, undiagnosed diseases through its genome sequencing and analysis. It works in collaboration with other organizations for the further discovery and development of novel therapeutics.HLI is headquartered in San Diego, California, the US.

Human Longevity Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Human Longevity Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Human Longevity Inc, Medical Devices Deals, 2011 to YTD 2017 9
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Human Longevity Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Human Longevity Acquires HiSeq X Ten Sequencing Systems From Illumina 11
Venture Financing 12
Celularity Raises Funds through Series A Financing 12
Human Longevity Raises US$70 Million In Venture Financing 13
Partnerships 14
Human Longevity Enters into Agreement with Merck 14
Cypher Genomics Enters into Research Agreement with Clinic for Special Children 15
Cypher Genomics Enters into Co-Development Agreement with Celgene 16
Cypher Genomics Enters into Co-Promotion Agreement with Illumina 17
Licensing Agreements 18
Human Longevity Enters into Licensing Agreement with Celgene Cellular Therapeutics for PSC-100 18
Acquisition 19
Human Longevity to Acquire LifebankUSA from Celgene Cellular Therapeutics 19
Human Longevity Inc – Key Competitors 20
Human Longevity Inc – Key Employees 21
Human Longevity Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
May 25, 2017: Saturnino Fanlo Joins Human Longevity As Chief Financial Officer 23
May 02, 2017: Human Longevity Enhances Senior Leadership Team, Making Key Hires to Strengthen Commercialization and Operations 24
Jan 04, 2017: Human Longevity Hires Cynthia Collins, Healthcare Industry Leader, as New Chief Executive Officer 26
Apr 06, 2016: Human Longevity Announces Promotions and Additions to Leadership Team 28
Product News 30
Aug 21, 2017: Celularity Accelerates Breakthrough Placental Discovery & Therapeutic Platform 30
Jul 03, 2017: Human Longevity Researchers Develop New Algorithm to Rapidly and Accurately Predict HLA Types Using Illumina Next Generation Sequencing Technology 31
Mar 06, 2017: In Largest Whole Genome Sequence Analysis Study, Human Longevity-Led Team Identifies Common-to-Rare Variants in the Human Blood Metabolome 32
Jan 12, 2016: Human Longevity to Offer Oncology Products Including Comprehensive Whole Germline, Tumor Genome and Whole Cancer Exome Products 33
Other Significant Developments 34
May 11, 2017: Human Longevity, Inc. Launches Pilot Program, Health Nucleus X 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Human Longevity Inc, Pharmaceuticals & Healthcare, Key Facts 2
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Human Longevity Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Human Longevity Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Human Longevity Inc, Medical Devices Deals, 2011 to YTD 2017 9
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Human Longevity Acquires HiSeq X Ten Sequencing Systems From Illumina 11
Celularity Raises Funds through Series A Financing 12
Human Longevity Raises US$70 Million In Venture Financing 13
Human Longevity Enters into Agreement with Merck 14
Cypher Genomics Enters into Research Agreement with Clinic for Special Children 15
Cypher Genomics Enters into Co-Development Agreement with Celgene 16
Cypher Genomics Enters into Co-Promotion Agreement with Illumina 17
Human Longevity Enters into Licensing Agreement with Celgene Cellular Therapeutics for PSC-100 18
Human Longevity to Acquire LifebankUSA from Celgene Cellular Therapeutics 19
Human Longevity Inc, Key Competitors 20
Human Longevity Inc, Key Employees 21
Human Longevity Inc, Other Locations 22
Human Longevity Inc, Subsidiaries 22

★海外企業調査レポート[Human Longevity Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Klockner Pentaplast GmbH & Co. KG:戦略・SWOT・企業財務分析
    Klockner Pentaplast GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Klockner Pentaplast GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PT Garuda Indonesia (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT Garuda Indonesia (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Garuda Indonesia (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • ViaSat Inc:企業のM&A・事業提携・投資動向
    ViaSat Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ViaSat Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Cochlear Ltd (COH):企業の製品パイプライン分析
    Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions. It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include c …
  • Costco Wholesale Corporation:企業の戦略・SWOT・財務情報
    Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Medifast, Inc. (MED):企業の財務・戦略的SWOT分析
    Medifast, Inc. (MED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sevan Marine ASA (SEVAN):石油・ガス:M&Aディール及び事業提携情報
    Summary Sevan Marine ASA (Sevan Marine) is an oil and gas company that offers engineering, design, and project execution of floating units for offshore applications. The company's floating production units include Hummingbird spirit, Voyageur spirit, Piranema spirit, Goliat FPSO and Western Isles FP …
  • Canadian Utilities Ltd (CU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Utilities Ltd (CUL), an ATCO company, is an electric utility. The company carries out electricity and natural gas distribution and transmission operations. It constructs and maintains electrical transmission and distribution lines and has stakes in generating plants through subsidia …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …
  • Reckitt Benckiser Group plc:企業の戦略・SWOT・財務情報
    Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report Summary Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Saudi Electricity Co (5110):電力:M&Aディール及び事業提携情報
    Summary Saudi Electricity Co (SEC) is an energy utility. Through its subsidiaries, the company generates, transmits and distributes electricity; and carries out operations of the fiber optic networks, trading, realization of renewable energy, and other. It produces electricity in gas, combined, stea …
  • Munchener Ruckversicherungs-Gesellschaft AG (Munich Re):戦略・SWOT・企業財務分析
    Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) - Strategy, SWOT and Corporate Finance Report Summary Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • MDF Instruments Direct Inc:企業の戦略的SWOT分析
    MDF Instruments Direct Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AviChina Industry & Technology Co., Ltd.:企業の戦略・SWOT・財務情報
    AviChina Industry & Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary AviChina Industry & Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • CooperSurgical Inc:医療機器:M&Aディール及び事業提携情報
    Summary CooperSurgical Inc (CooperSurgical), a subsidiary of The Cooper Companies Inc is a medical device company that offers surgical instrument. The company offers surgical products, clinic and office products, labor and delivery products, and critical care products. Its surgical products include …
  • Ascend Therapeutics US LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascend Therapeutics US LLC (Ascend Therapeutics), a subsidiary of Besins Healthcare SA, is a pharmaceutical company that offers women’s healthcare products. The company discovers, develops and markets transdermal drug delivery products. Its product includes estrogel, a non patch transdermal …
  • Semiconductor Manufacturing International Corporation:企業の戦略・SWOT・財務情報
    Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report Summary Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • China Resources Zizhu Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Zizhu Pharmaceutical Co Ltd (Zizhu Pharmaceutical) is a provider of pharmaceutical development, manufacture, and marketing programs. The company offers dietary supplements, women healthcare products, ophthalmology medicines, APIs and intermediates, anesthetic, biological agen …
  • Parker Drilling Co (PKD):石油・ガス:M&Aディール及び事業提携情報
    Summary Parker Drilling Co (Parker) is a provider of drilling solutions to the energy industry. It offers services which include land drilling, barge drilling, well services, rig design, construction, operations and maintenance among others. The company provides offshore and onshore contract drillin …
  • Veridian Corporation:発電所・企業SWOT分析
    Veridian Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆